Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Non-cash Items (2016 - 2020)

United Therapeutics (UTHR) has disclosed Non-cash Items for 10 consecutive years, with $15.6 million as the latest value for Q1 2020.

  • Quarterly Non-cash Items rose 301.5% to $15.6 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $15.6 million through Mar 2020, up 301.5% year-over-year, with the annual reading at $24.1 million for FY2019, 26.3% down from the prior year.
  • Non-cash Items hit $15.6 million in Q1 2020 for United Therapeutics, down from $24.1 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $171.2 million in Q4 2017 to a low of $3.2 million in Q4 2016.
  • Historically, Non-cash Items has averaged $50.7 million across 5 years, with a median of $24.1 million in 2019.
  • Biggest five-year swings in Non-cash Items: crashed 98.45% in 2016 and later soared 5197.33% in 2017.
  • Year by year, Non-cash Items stood at $3.2 million in 2016, then skyrocketed by 5197.33% to $171.2 million in 2017, then tumbled by 80.9% to $32.7 million in 2018, then decreased by 26.3% to $24.1 million in 2019, then crashed by 35.27% to $15.6 million in 2020.
  • Business Quant data shows Non-cash Items for UTHR at $15.6 million in Q1 2020, $24.1 million in Q4 2019, and $108.4 million in Q3 2019.